1.
OECD.
OECD obesity update.
2017.
2018.
Available from: http://www.oecd.org/health/obesity-update.htm.
2.
World Health Organization.
Obesity and overweight.
2017.
Available from http://www.who.int
3.Sakai NS,
Taylor SA,
Chouhan MD.
Obesity,
metabolic disease and the pancreas – Quantitative imaging of pancreatic fat. Br J Radiol 2018; 91: 20180267.
4.Wong VW, Wong GL, Yeung DK, Abrigo JM, Kong AP, Chan RS, Chim AM, Shen J, Ho CS, Woo J, Chu WC, Chan HL.Fatty pancreas,
insulin resistance,
and β-cell function: a population study using fat-water magnetic resonance imaging.Am J Gastroenterol. 2014; 109(4):589-97.
5.Catanzaro R, Cuffari B, Italia A, Marotta F.Exploring the metabolic syndrome: Nonalcoholic fatty pancreas disease. World J Gastroenterol. 2016; 22(34):7660-75.
6.Della Corte C, Mosca A, Majo F, Lucidi V, Panera N, Giglioni E, Monti L, Stronati L, Alisi A, Nobili V.Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat. Clin Endocrinol (Oxf). 2015; 83(5):656-62.
7.Tariq H, Nayudu S, Akella S, Glandt M, Chilimuri S.Non-Alcoholic Fatty Pancreatic Disease: A Review of Literature. Gastroenterology Res. 2016; 9(6):87-91
8.Smits MM, van Geenen EJ.The clinical significance of pancreatic
steatosis.Nat Rev Gastroenterol Hepatol. 2011; 8(3):169-77.
9.Yamazaki H, Tsuboya T, Katanuma A, Kodama Y, Tauchi S, Dohke M, Maguchi H.Lack of Independent Association Between Fatty Pancreas and Incidence of Type 2 Diabetes: 5-Year Japanese Cohort Study. Diabetes Care. 2016; 39(10):1677-83.
10.
Ozturk K, Dogan T, Celikkanat S, Ozen A, Demirci H, Kurt O, Turker T, Yilmaz Y, Uygun A.
The association of fatty pancreas with subclinical atherosclerosis in nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2018; 30(4):411-417.